News

Evonile Pharma Limited, formerly known as Novartis India Limited, will seek to raise funds through a rights issue of equity shares with a face value of Rs 5 each to its eligible shareholders, according to a regulatory filing with the BSE Limited on October 05, 2026. The company’s Board of Directors is scheduled to meet on October 08, 2026, to consider the terms and conditions of the proposed fund-raising, which is subject to regulatory approvals. Trading window for company insiders has been closed from October 01, 2026, until November 05, 2026.

Novartis India Limited will hold a board meeting on Tuesday, November 03, 2026, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026, according to a regulatory filing with the BSE Limited. The trading window for the company`s designated persons will be closed from October 01, 2026, and will reopen 48 hours after the financial results are declared.

Net profit of Novartis India rose 16.62% to Rs 32.21 crore in the quarter ended June 2026 as against Rs 27.62 crore during the previous quarter ended June 2025. Sales rose 18.57% to Rs 103.81 crore in the quarter ended June 2026 as against Rs 87.55 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales103.8187.55 19 OPM %33.6331.11 - PBDT43.5937.75 15 PBT43.1737.22 16 NP32.2127.62 17 Powered by Capital Market - Live News

Novartis India will hold a meeting of the Board of Directors of the Company on 23 July 2026.

Net profit of Novartis India declined 13.82% to Rs 25.25 crore in the quarter ended March 2026 as against Rs 29.30 crore during the previous quarter ended March 2025. Sales rose 7.95% to Rs 90.55 crore in the quarter ended March 2026 as against Rs 83.88 crore during the previous quarter ended March 2025.For the full year,net profit declined 7.65% to Rs 93.18 crore in the year ended March 2026 as against Rs 100.90 crore during the previous year ended March 2025. Sales declined 0.54% to Rs 354.33 crore in the year ended March 2026 as against Rs 356.27 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales90.5583.88 8 354.33356.27 -1 OPM %22.7728.51 -26.5625.66 - PBDT30.5634.42 -11 131.61132.61 -1 PBT30.1433.89 -11 129.66130.42 -1 NP25.2529.30 -14 93.18100.90 -8 Powered by Capital Market - Live News